Key facts
- VXRT - Vaxart, Inc. has 20 insiders with reported activity on this page.
- Net insider value flow over the last year: +$90,090.
- Recent transaction rows are available for direct filing-level review.
Issuer insider activity is sourced from SEC Forms 3, 4, and 5.
Net insider flow leans to buying over the last 12 months. Net value: +$90,090.
$90,090
Shares: 236,668
Insiders: 3
$0
Shares: 0
Insiders: 0
+$90,090
Shares: +236,668
Insiders: 3
| Window (months) | Buy shares | Sell shares | Buy $ | Sell $ | Net $ |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 60,000 | 0 | $24,106 | $0 | +$24,106 |
| 9-12 | 176,668 | 0 | $65,984 | $0 | +$65,984 |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Cezar Andrei Floroiu | President, Chief Exec Officer, Director | $1,082,037 | Mixed | 17 Mar 2023 | ||
| Steven Lo | President, Chief Exec Officer, Director | $895,653 | Mixed | 24 Mar 2026 | ||
| Phillip E. Lee | Chief Financial Officer | $360,149 | Mixed | 24 Mar 2025 | ||
| Michael J. Finney | Director | $330,334 | Mixed | 13 Jun 2025 | ||
| Jeroen Nicolaas Grasman | Chief Financial Officer | $327,363 | Median | 19 May 2026 | ||
| Sean Tucker | SVP, Chief Scientific Officer | $326,770 | Mixed | 28 Mar 2026 | ||
| James F. Cummings | Chief Medical Officer | $320,134 | Mixed | 28 Mar 2026 | ||
| Todd C. Davis | Director | $300,913 | Mixed | 04 Aug 2022 | ||
| Edward B. Berg | SVP, General Counsel | $261,659 | Mixed | 24 Mar 2026 | ||
| Kevin Finney | Director | $75,765 | +$61,934 | +448% | Filing P/S | 17 Jul 2025 |
| W. Mark Watson | Director | $50,518 | +$12,235 | +32% | Filing P/S | 17 Nov 2025 |
| James B. Breitmeyer | Director | $47,477 | Median | 23 Apr 2026 | ||
| Robert A. Yedid | Director | $44,837 | Mixed | 11 Jun 2024 | ||
| Elaine J. Heron | Director | $39,109 | +$15,921 | +69% | Filing P/S | 17 Nov 2025 |
| David E. Wheadon | Director | $21,972 | Mixed | 13 Jun 2025 | ||
| Julie M. Cherrington | Director | $14,859 | Mixed | 04 Aug 2022 | ||
| Fuad Ahmad | Interim CFO | $11,950 | Mixed | 22 Jun 2022 | ||
| Wouter Latour | Director | Mixed | 06 May 2021 | |||
| Margaret Echerd | SVP, Principal Accntng Officer | Mixed | 30 Nov 2021 | |||
| Karen J. Wilson | Director | Mixed | 16 Jun 2021 |
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Sio Capital Management, LLC |
13D/G
|
— |
2.4%
|
5,583,448
|
$2,400,883 | -$2,550,703 | 31 Mar 2025 | |
| Heritage Wealth Advisors |
13F
|
Company |
0.01%
|
29,655
|
$17,941 | — | 31 Mar 2026 | |
| LVM CAPITAL MANAGEMENT LTD/MI |
13F
|
Company |
0.01%
|
25,000
|
$15,000 | — | 31 Mar 2026 | |
| Ascentis Independent Advisors |
13F
|
Company |
0%
|
2,000
|
$1,210 | — | 31 Mar 2026 | |
| First Command Advisory Services, Inc. |
13F
|
Company |
0%
|
40
|
$24 | — | 31 Mar 2026 | |
| Archer Investment Corp |
13F
|
Company |
0%
|
15
|
$9 | — | 31 Mar 2026 | |
| Cezar Andrei Floroiu |
3/4/5
|
President, Chief Exec Officer, Director |
—
mixed-class rows
|
1,202,735
mixed-class rows
|
$1,082,037 | — | 17 Mar 2023 | |
| Steven Lo |
3/4/5
|
President, Chief Exec Officer, Director |
—
mixed-class rows
|
4,128,606
mixed-class rows
|
$895,653 | — | 24 Mar 2026 | |
| Phillip E. Lee |
3/4/5
|
Chief Financial Officer |
—
mixed-class rows
|
1,241,619
mixed-class rows
|
$360,149 | — | 24 Mar 2025 | |
| Michael J. Finney |
3/4/5
|
Director |
—
mixed-class rows
|
798,240
mixed-class rows
|
$330,334 | — | 13 Jun 2025 | |
| Jeroen Nicolaas Grasman |
3/4/5
|
Chief Financial Officer |
—
mixed-class rows
|
1,000,605
mixed-class rows
|
$327,363 | — | 19 May 2026 | |
| Sean Tucker |
3/4/5
|
SVP, Chief Scientific Officer |
—
mixed-class rows
|
1,353,336
mixed-class rows
|
$326,770 | — | 28 Mar 2026 | |
| James F. Cummings |
3/4/5
|
Chief Medical Officer |
—
mixed-class rows
|
1,379,177
mixed-class rows
|
$320,134 | — | 28 Mar 2026 | |
| Todd C. Davis |
3/4/5
|
Director |
—
mixed-class rows
|
170,129
mixed-class rows
|
$300,913 | — | 04 Aug 2022 | |
| Edward B. Berg |
3/4/5
|
SVP, General Counsel |
—
mixed-class rows
|
980,368
mixed-class rows
|
$261,659 | — | 24 Mar 2026 | |
| Kevin Finney |
3/4/5
|
Director |
—
mixed-class rows
|
241,163
mixed-class rows
|
$75,765 | +$61,934 | 17 Jul 2025 | |
| W. Mark Watson |
3/4/5
|
Director |
—
mixed-class rows
|
219,525
mixed-class rows
|
$50,518 | +$12,235 | 17 Nov 2025 | |
| James B. Breitmeyer |
3/4/5
|
Director |
—
mixed-class rows
|
236,200
mixed-class rows
|
$47,477 | — | 23 Apr 2026 | |
| Robert A. Yedid |
3/4/5
|
Director |
—
mixed-class rows
|
129,890
mixed-class rows
|
$44,837 | — | 11 Jun 2024 | |
| Elaine J. Heron |
3/4/5
|
Director |
—
mixed-class rows
|
191,966
mixed-class rows
|
$39,109 | +$15,921 | 17 Nov 2025 | |
| David E. Wheadon |
3/4/5
|
Director |
—
mixed-class rows
|
142,150
mixed-class rows
|
$21,972 | — | 13 Jun 2025 | |
| Julie M. Cherrington |
3/4/5
|
Director |
—
mixed-class rows
|
43,497
mixed-class rows
|
$14,859 | — | 04 Aug 2022 | |
| Fuad Ahmad |
3/4/5
|
Interim CFO |
—
class O/S missing
|
5,000
|
$11,950 | — | 22 Jun 2022 | |
| Wouter Latour |
3/4/5
|
Director |
—
class O/S missing
|
700,000
|
— | — | 06 May 2021 | |
| Margaret Echerd |
3/4/5
|
SVP, Principal Accntng Officer |
—
class O/S missing
|
26,416
|
— | — | 30 Nov 2021 | |
| Karen J. Wilson |
3/4/5
|
Director |
—
class O/S missing
|
15,097
|
— | — | 16 Jun 2021 |
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Jeroen Nicolaas Grasman | VXRT | Common Stock | Tax liability | -5.44% | -31,395 | 545,605 | 19 May 2026 | Direct | ||
| James B. Breitmeyer | VXRT | Common Stock | Award | 78,800 | 78,800 | 23 Apr 2026 | Direct | |||
| James B. Breitmeyer | VXRT | Stock Option (right to buy) | Award | 157,400 | 157,400 | 23 Apr 2026 | Direct | |||
| Sean Tucker | VXRT | Common Stock | Tax liability | -0.44% | -3,924 | 882,811 | 28 Mar 2026 | Direct | ||
| James F. Cummings | VXRT | Common Stock | Tax liability | -0.35% | -3,292 | 924,177 | 28 Mar 2026 | Direct | ||
| Edward B. Berg | VXRT | Common Stock | Tax liability | -4.6% | -36,418 | 755,368 | 24 Mar 2026 | Direct | ||
| James F. Cummings | VXRT | Common Stock | Tax liability | -3.19% | -30,551 | 927,469 | 24 Mar 2026 | Direct | ||
| Steven Lo | VXRT | Common Stock | Tax liability | -4.83% | -126,028 | 2,485,606 | 24 Mar 2026 | Direct | ||
| Sean Tucker | VXRT | Common Stock | Tax liability | -3.94% | -36,418 | 886,735 | 24 Mar 2026 | Direct | ||
| Edward B. Berg | VXRT | Common Stock | Tax liability | -1.01% | -8,072 | 791,786 | 18 Mar 2026 | Direct | ||
| James F. Cummings | VXRT | Common Stock | Tax liability | -0.7% | -6,772 | 958,020 | 18 Mar 2026 | Direct | ||
| Steven Lo | VXRT | Common Stock | Tax liability | -0.85% | -22,425 | 2,611,634 | 18 Mar 2026 | Direct | ||
| Sean Tucker | VXRT | Common Stock | Tax liability | -0.87% | -8,072 | 923,153 | 18 Mar 2026 | Direct | ||
| Steven Lo | VXRT | Common Stock | Award | 47.4% | 846,500 | 2,634,059 | 16 Mar 2026 | Direct | ||
| Steven Lo | VXRT | Stock Option (right to buy) | Award | 1,543,000 | 1,543,000 | 16 Mar 2026 | Direct | |||
| Sean Tucker | VXRT | Common Stock | Award | 27.4% | 200,000 | 931,225 | 16 Mar 2026 | Direct | ||
| Sean Tucker | VXRT | Stock Option (right to buy) | Award | 410,000 | 410,000 | 16 Mar 2026 | Direct | |||
| Jeroen Nicolaas Grasman | VXRT | Common Stock | Award | 64.9% | 227,000 | 577,000 | 16 Mar 2026 | Direct | ||
| Jeroen Nicolaas Grasman | VXRT | Stock Option (right to buy) | Award | 455,000 | 455,000 | 16 Mar 2026 | Direct | |||
| James F. Cummings | VXRT | Common Stock | Award | 30.8% | 227,000 | 964,792 | 16 Mar 2026 | Direct | ||
| James F. Cummings | VXRT | Stock Option (right to buy) | Award | 455,000 | 455,000 | 16 Mar 2026 | Direct | |||
| Edward B. Berg | VXRT | Common Stock | Award | 16.8% | 115,000 | 799,858 | 16 Mar 2026 | Direct | ||
| Edward B. Berg | VXRT | Stock Option (right to buy) | Award | 225,000 | 225,000 | 16 Mar 2026 | Direct | |||
| Edward B. Berg | VXRT | Common Stock | Tax liability | -1.33% | -9,265 | 684,858 | 02 Feb 2026 | Direct | ||
| James F. Cummings | VXRT | Common Stock | Tax liability | -1.07% | -7,965 | 737,792 | 02 Feb 2026 | Direct | ||
| Sean Tucker | VXRT | Common Stock | Tax liability | -1.25% | -9,265 | 731,225 | 02 Feb 2026 | Direct | ||
| Steven Lo | VXRT | Common Stock | Tax liability | -2.94% | -54,153 | 1,787,559 | 04 Dec 2025 | Direct | ||
| Steven Lo | VXRT | Common Stock | Award | 8.95% | 151,351 | 1,841,712 | 04 Dec 2025 | Direct | ||
| W. Mark Watson | VXRT | Common Stock | Purchase | 19.2% | $8,185 | $0.4093 | 20,000 | 124,125 | 17 Nov 2025 | Direct |
| Elaine J. Heron | VXRT | Common Stock | Purchase | 70.7% | $15,921 | $0.3980 | 40,000 | 96,566 | 17 Nov 2025 | Direct |
| Kevin Finney | VXRT | Common Stock | Purchase | 95.4% | $36,000 | $0.3600 | 100,000 | 204,771 | 15 Aug 2025 | Direct |
| Kevin Finney | VXRT | Common Stock | Purchase | 32.8% | $9,832 | $0.3800 | 25,874 | 104,771 | 30 Jul 2025 | Direct |
| W. Mark Watson | VXRT | Common Stock | Purchase | 10.6% | $4,050 | $0.4050 | 10,000 | 104,125 | 29 Jul 2025 | Direct |
| Kevin Finney | VXRT | Common Stock | Purchase | 34% | $8,000 | $0.4000 | 20,000 | 78,897 | 28 Jul 2025 | Direct |
| Kevin Finney | VXRT | Common Stock | Purchase | 51.4% | $7,800 | $0.3900 | 20,000 | 58,897 | 25 Jul 2025 | Direct |
| Kevin Finney | VXRT | Common Stock | Purchase | 2.08% | $302 | $0.3800 | 794 | 38,897 | 17 Jul 2025 | Direct |
| Kevin Finney | VXRT | Common Stock | Award | 19.1% | 6,103 | 38,103 | 13 Jun 2025 | Direct | ||
| Kevin Finney | VXRT | Stock Option (right to buy) | Award | 36,392 | 36,392 | 13 Jun 2025 | Direct | |||
| W. Mark Watson | VXRT | Common Stock | Award | 20.5% | 16,000 | 94,125 | 13 Jun 2025 | Direct | ||
| W. Mark Watson | VXRT | Stock Option (right to buy) | Award | 95,400 | 95,400 | 13 Jun 2025 | Direct | |||
| Elaine J. Heron | VXRT | Common Stock | Award | 39.4% | 16,000 | 56,566 | 13 Jun 2025 | Direct | ||
| Elaine J. Heron | VXRT | Stock Option (right to buy) | Award | 95,400 | 95,400 | 13 Jun 2025 | Direct | |||
| David E. Wheadon | VXRT | Common Stock | Award | 52% | 16,000 | 46,750 | 13 Jun 2025 | Direct | ||
| David E. Wheadon | VXRT | Stock Option (right to buy) | Award | 95,400 | 95,400 | 13 Jun 2025 | Direct | |||
| Michael J. Finney | VXRT | Common Stock | Award | 2.33% | 16,000 | 702,840 | 13 Jun 2025 | Direct | ||
| Michael J. Finney | VXRT | Stock Option (right to buy) | Award | 95,400 | 95,400 | 13 Jun 2025 | Direct |